Your browser doesn't support javascript.
loading
Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report.
Alsaati, Alshaimaa M; Alasiri, Meshal M; Alansari, Bayan A; Mulla, Wed Y; Al-Marzouki, Adel F; Daous, Yara M; Radhwi, Osman.
Afiliação
  • Alsaati AM; Medical School, King Abdulaziz University Hospital, Jeddah, SAU.
  • Alasiri MM; Medical School, King Abdulaziz University Hospital, Jeddah, SAU.
  • Alansari BA; Medical School, King Abdulaziz University Hospital, Jeddah, SAU.
  • Mulla WY; Medical School, King Abdulaziz University Hospital, Jeddah, SAU.
  • Al-Marzouki AF; Hematology, King Abdulaziz University Hospital, Jeddah, SAU.
  • Daous YM; Hematopathology, King Abdulaziz University Hospital, Jeddah, SAU.
  • Radhwi O; Hematology, King Abdulaziz University Hospital, Jeddah, SAU.
Cureus ; 15(1): e33239, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36601362
ABSTRACT
Mantle cell lymphoma (MCL) is a rare subtype of B-cell lymphoma that can present in a variety of ways, including the leukemic phase, where it can occasionally be mistaken for acute leukemia due to the unusually high or rapidly growing number of leukocytes and the presence of circulating cancer cells that are morphologically similar to leukemic blasts in myeloid or acute lymphoblastic leukemia. We present the case of an 83-year-old Yemeni woman with multiple comorbidities who presented with abdominal pain and constitutional symptoms. She was found to have diffuse lymphadenopathy on clinical and radiological assessments. Her white blood cell count at presentation was 221 × 109/L with marked monocytosis (72.8%). Lymph node biopsy and bone marrow studies, including CCND1/IGH molecular studies, confirmed MCL, the pleomorphic subtype. The patient was deemed unfit for standard-of-care chemotherapy and was started on single-agent rituximab with a slow introduction to ibrutinib but succumbed to death after two weeks of ibrutinib 280 mg daily. This case serves as a reminder to keep an open mind and take into account atypical disease presentations when formulating differential diagnoses to prevent late diagnosis and any unnecessary intervention that can postpone appropriate therapy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article